These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 10825236

  • 1. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells.
    Ducos K, Panterne B, Fortunel N, Hatzfeld A, Monier MN, Hatzfeld J.
    J Cell Physiol; 2000 Jul; 184(1):80-5. PubMed ID: 10825236
    [Abstract] [Full Text] [Related]

  • 2. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay.
    Fortunel N, Hatzfeld J, Kisselev S, Monier MN, Ducos K, Cardoso A, Batard P, Hatzfeld A.
    Stem Cells; 2000 Jul; 18(2):102-11. PubMed ID: 10742382
    [Abstract] [Full Text] [Related]

  • 3. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW.
    Stem Cells; 2003 Jul; 21(5):557-67. PubMed ID: 12968110
    [Abstract] [Full Text] [Related]

  • 4. The high proliferative potential-quiescent (HPP-Q) cell assay allows an optimized evaluation of gene transfer efficiency into primitive hematopoietic stem/progenitor cells.
    Ducos K, Hatzfeld A, Héron A, Fortunel N, Kisselev S, Héron C, Monier MN, Hatzfeld J.
    Gene Ther; 2000 Oct; 7(20):1790-4. PubMed ID: 11083502
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1).
    Cheng T, Shen H, Rodrigues N, Stier S, Scadden DT.
    Blood; 2001 Dec 15; 98(13):3643-9. PubMed ID: 11739168
    [Abstract] [Full Text] [Related]

  • 6. Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells.
    Kang SH, Bang YJ, Jong HS, Seo JY, Kim NK, Kim SJ.
    Br J Cancer; 1999 Jun 15; 80(8):1144-9. PubMed ID: 10376964
    [Abstract] [Full Text] [Related]

  • 7. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells.
    Ito D, Fujimoto K, Doi R, Koizumi M, Toyoda E, Mori T, Kami K, Kawaguchi Y, Whitehead R, Imamura M.
    Surgery; 2004 Aug 15; 136(2):364-74. PubMed ID: 15300203
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
    Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC.
    Mol Cell Biol; 2005 Sep 15; 25(18):8097-107. PubMed ID: 16135801
    [Abstract] [Full Text] [Related]

  • 11. [The maintenance of cord blood CD34+ progenitor cells with plant lectin FRIL in vitro and the expression of related cell cycle modulator HTm4 and HTm4S].
    Xie XY, Xie C, Shi W, Li J, Li YH, Wang DM, Bai CX, Chen L, Pei XT.
    Sheng Li Xue Bao; 2004 Jun 25; 56(3):306-12. PubMed ID: 15224142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neurokinin-A inhibits cell cycle activators in K562 cells and activates Smad 4 through a non-canonical pathway: a novel method in neural-hematopoietic axis.
    Ricardo M, Trzaska KA, Rameshwar P.
    J Neuroimmunol; 2008 Nov 15; 204(1-2):85-91. PubMed ID: 18760489
    [Abstract] [Full Text] [Related]

  • 15. A neutralizing anti-TGF-beta1 antibody promotes proliferation of CD34+Thy-1+ peripheral blood progenitors and increases the number of transduced progenitors.
    Imbert AM, Bagnis C, Galindo R, Chabannon C, Mannoni P.
    Exp Hematol; 1998 May 15; 26(5):374-81. PubMed ID: 9590653
    [Abstract] [Full Text] [Related]

  • 16. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
    Van Ranst PC, Snoeck HW, Lardon F, Lenjou M, Nijs G, Weekx SF, Rodrigus I, Berneman ZN, Van Bockstaele DR.
    Exp Hematol; 1996 Nov 15; 24(13):1509-15. PubMed ID: 8950234
    [Abstract] [Full Text] [Related]

  • 17. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
    Gazitt Y, Reddy SV, Alcantara O, Yang J, Boldt DH.
    J Cell Physiol; 2001 Apr 15; 187(1):124-35. PubMed ID: 11241357
    [Abstract] [Full Text] [Related]

  • 18. Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor beta1.
    Sugiyama A, Nagaki M, Shidoji Y, Moriwaki H, Muto Y.
    Biochem Biophys Res Commun; 1997 Sep 18; 238(2):539-43. PubMed ID: 9299547
    [Abstract] [Full Text] [Related]

  • 19. p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells.
    Fan G, Ma X, Wong PY, Rodrigues CM, Steer CJ.
    Apoptosis; 2004 Mar 18; 9(2):211-21. PubMed ID: 15004518
    [Abstract] [Full Text] [Related]

  • 20. Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta.
    Fortunel NO, Hatzfeld JA, Monier MN, Hatzfeld A.
    Oncol Res; 2003 Mar 18; 13(6-10):445-53. PubMed ID: 12725536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.